Affimed NV (AFMD)
3.87
+0.14
(+3.61%)
USD |
NASDAQ |
Nov 14, 12:37
Affimed Market Cap: 60.68M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 58.57M |
| November 12, 2024 | 58.96M |
| November 11, 2024 | 59.90M |
| November 08, 2024 | 60.37M |
| November 07, 2024 | 60.06M |
| November 06, 2024 | 55.98M |
| November 05, 2024 | 57.39M |
| November 04, 2024 | 51.28M |
| November 01, 2024 | 51.12M |
| October 31, 2024 | 50.65M |
| October 30, 2024 | 52.37M |
| October 29, 2024 | 52.53M |
| October 28, 2024 | 52.84M |
| October 25, 2024 | 52.14M |
| October 24, 2024 | 52.06M |
| October 23, 2024 | 53.16M |
| October 22, 2024 | 54.57M |
| October 21, 2024 | 53.31M |
| October 18, 2024 | 55.67M |
| October 17, 2024 | 51.90M |
| October 16, 2024 | 52.22M |
| October 15, 2024 | 49.00M |
| October 14, 2024 | 48.92M |
| October 11, 2024 | 47.04M |
| October 10, 2024 | 46.89M |
| Date | Value |
|---|---|
| October 09, 2024 | 48.61M |
| October 08, 2024 | 49.24M |
| October 07, 2024 | 49.55M |
| October 04, 2024 | 50.34M |
| October 03, 2024 | 51.12M |
| October 02, 2024 | 51.59M |
| October 01, 2024 | 51.90M |
| September 30, 2024 | 52.69M |
| September 27, 2024 | 52.69M |
| September 26, 2024 | 51.75M |
| September 25, 2024 | 51.90M |
| September 24, 2024 | 53.16M |
| September 23, 2024 | 53.31M |
| September 20, 2024 | 57.86M |
| September 19, 2024 | 62.10M |
| September 18, 2024 | 63.04M |
| September 17, 2024 | 63.82M |
| September 16, 2024 | 62.41M |
| September 13, 2024 | 62.72M |
| September 12, 2024 | 60.68M |
| September 11, 2024 | 60.37M |
| September 10, 2024 | 61.00M |
| September 09, 2024 | 61.47M |
| September 06, 2024 | 58.96M |
| September 05, 2024 | 59.43M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
46.89M
Minimum
Oct 10 2024
1.356B
Maximum
Apr 28 2021
349.01M
Average
237.90M
Median
May 28 2020
Market Cap Benchmarks
| InflaRx NV | 127.19M |
| BioNTech SE | 26.98B |
| Immatics NV | 870.21M |
| CureVac NV | 602.28M |
| ATAI Life Sciences NV | 214.78M |
Market Cap Related Metrics
| PS Ratio | 20.02 |
| Price to Book Value | 1.972 |
| Price | 3.87 |
| Earnings Yield | -147.4% |